Blanket Purchase Agreement 36F79721D0073-36C24523A0023

Award Date 1/1/23
Last Date to Order 9/30/23
Ultimate Awardee
Abbott Laboratories
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Abbott Rapid DX North America LLC, doing business as Alere, an indefinite-delivery/indefinite-quantity contract with a potential value of $5.2 million to provide COVID-19 testing supplies. Abbott Laboratories is the prime contractor supplying tests under its parent General Services Administration Schedule 65-VII for in vitro diagnostics, reagents, and tests. Three firm fixed price...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 has awarded an indefinite delivery contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide COVID-19 antigen testing supplies and services. The single-award contract has a ceiling value of $995,165.44 and runs through January 2026. Under this contract, Abbott will deliver its BinaxNOW rapid COVID-19 antigen tests and related diagnostic materials to support coronavirus testing...
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 (VISN 6) awarded a Blanket Purchase Agreement (BPA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide BinaxNOW COVID-19 antigen test kits. The BPA, valued at $240,608.97, has an ultimate completion date of September 30, 2024 and was awarded without any set-aside designations. This BPA is part of Abbott Rapid DX North America LLC's Federal Supply Schedule (FSS) 65-VII contract...
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) awarded a Blanket Purchase Agreement (BPA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the provision of BinaxNOW COVID-19 antigen test kits and related supplies. The BPA, valued at up to $740,000, was issued against Abbott's GSA Schedule 65-VII contract for in vitro diagnostics, reagents, and tests. This award supports VISN 23's ongoing COVID-19 testing and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a single award Blanket Purchase Agreement to Abbott Rapid DX North America LLC for Abbott Binax ID NOW COVID-19 antigen test kits. The potential value of the BPA is $744,842.40 to supply test kits through December 31, 2022 for use across VISN 1 facilities. The originating pre-solicitation notice sought market research for a five-year BPA to supply Abbott Binax NOW COVID Ag Card testing...
The Department of Veterans Affairs Strategic Acquisition Center Frederick awarded Abbott Rapid DX North America LLC an indefinite delivery contract with a potential value of $1,424,500.00 to provide Abbott ID NOW Analyzer instruments and accessories for rapid point-of-service testing to support COVID-19 response efforts. Against this contract vehicle, multiple firm fixed price delivery orders were issued for the analyzers and supplies to enable timely diagnostic testing at VA medical centers and...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the procurement of BinaxNOW COVID-19 antigen testing kits, self-testing kits, and test card control kits. The $1,177,761.36 single-award BPA was established on January 3, 2022 with a period of performance through January 2, 2023. The BPA was not set aside for any specific business category and was issued under the GSA Schedule...
The U.S. Department of Veterans Affairs (VA) has awarded a series of firm-fixed-price delivery orders under a single indefinite delivery contract (IDC) to Abbott Laboratories Inc., a global healthcare company, to provide a variety of COVID-19 testing products and services. These include SARS serology reagent test kits, SARS COV-2 testing services, and COVID-19 testing reagents and supplies. The delivery orders, valued at over $4.8 million in total, will support the VA's Veterans Integrated...
This federal contract IDV is a multiple award GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests awarded to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract has a ceiling value of $300 million and a performance period through January 3, 2026. The agency customer is the U.S. Department of Veterans Affairs (VA) and its various regional Veterans Integrated Service Networks (VISNs). Under this IDV, Abbott Rapid DX North America LLC has received...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a single award indefinite delivery contract to Abbott Laboratories Inc., Diagnostics Division. Task orders issued against the contract include SARS COVID testing, Abbott Architect SARS CoV-2 IgG/IgM reagents for the Orlando VA Medical Center, and additional SARS COVID testing. The total potential value of the contract is $784,262. Performance locations include North Chicago,...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded multiple firm fixed price calls against Abbott Rapid DX North America LLC's General Services Administration Federal Supply Schedule contract for Invitro Diagnostics, Reagents, and Tests. Abbott Rapid DX North America LLC, doing business as Alere and a subsidiary of Abbott Laboratories, will deliver Abbott's BINAXNOW COVID-19 rapid antigen tests to the VA location in Lockhart, Florida under the task orders. The task orders were awarded between January 1, 2023 and October 1, 2023 and have periods of performance through September 30, 2023 and September 30, 2024. The calls were placed without set-aside designations and have cumulative potential values ranging from approximately $2,400 to $233,500. The calls aim to procure Abbott's BINAXNOW antigen test kits to support the VA network's COVID-19 screening and testing programs for veterans served by its facilities.

The General Services Administration Schedule 65-VII for Invitro Diagnostics, Reagents, and Tests served as the contract vehicle. This pre-established, multiple award schedule incorporates pricing and terms for COVID-19 testing supplies to facilitate rapid procurement by federal agencies in response to the ongoing public health emergency. The calls issued by the VA network against Abbott's schedule contract further the agency's mission to provide affected veterans access to necessary medical supplies and pandemic mitigation resources.

Generated 1/4/24, 5:14 PM